ZIOPHARM Oncology (ZIOP) Weak On High Volume Today
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
Trade-Ideas LLC identified
(
) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified ZIOPHARM Oncology as such a stock due to the following factors:
- ZIOP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $80.0 million.
- ZIOP has traded 603,095 shares today.
- ZIOP is trading at 2.21 times the normal volume for the stock at this time of day.
- ZIOP is trading at a new low 6.02% below yesterday's close.
'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZIOP with the Ticky from Trade-Ideas. See the FREE profile for ZIOP NOW at Trade-Ideas
More details on ZIOP:
ZIOPHARM Oncology, Inc., a biotechnology company, engages in the discovery and development of cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer.
The average volume for ZIOPHARM Oncology has been 1.0 million shares per day over the past 30 days. ZIOPHARM Oncology has a market cap of $488.9 million and is part of the health care sector and drugs industry. The stock has a beta of 0.49 and a short float of 22.8% with 2.92 days to cover. Shares are up 12.9% year-to-date as of the close of trading on Friday.
null